SWK Holdings Corporation is a life science focused specialty finance company. The Company’s segments include Finance Receivables and Pharmaceutical Development. Its Finance Receivables segment is a healthcare capital provider, which offers customized financing solutions to a range of life science companies, institutions, and inventors. This segment is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Its Pharmaceutical Development segment operates through its subsidiary Enteris BioPharma, Inc. (Enteris). Enteris is a clinical development and manufacturing organization providing development services to pharmaceutical partners as well as innovative formulation solutions built around its oral drug delivery technologies.
Ticker SymbolSWKH
Company nameSWK Holdings Corp
IPO dateSep 22, 1999
Founded at1999
CEOMr. Joe D. Staggs
Number of employees24
Security typeOrdinary Share
Fiscal year-endSep 22
Address5956 Sherry Lane
CityDALLAS
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code75225
Phone12142177253
Websitehttps://www.swkhold.com/
Ticker SymbolSWKH
IPO dateSep 22, 1999
Founded at1999
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data